Literature DB >> 7785066

Maternal mortality estimation: separating pregnancy-related and non-pregnancy-related risks.

G Stecklov1.   

Abstract

The increased availability of survey data and improved estimation techniques have furthered our understanding of maternal mortality in developing countries. Both the indirect and direct sisterhood methods of estimation depend on time-of-death information from surveys. This report proposes a method for calculating two rates, one during the pregnancy period and one outside of it. Analysis of both rates provides more information about mortality associated with pregnancy than do methods that only produce one rate. The pregnancy-related mortality rate can be estimated by assuming that non-pregnancy-related risks are constant, irrespective of whether women are pregnant or not. An estimated 69 percent of deaths in Bolivia during pregnancy may be pregnancy related; this result is significantly lower than that obtained using the traditional sisterhood method. In certain cases, this result may be viewed as a plausible lower bound. A variety of estimates should probably be used for policy purposes.

Entities:  

Mesh:

Year:  1995        PMID: 7785066

Source DB:  PubMed          Journal:  Stud Fam Plann        ISSN: 0039-3665


  3 in total

1.  Estimating pregnancy-related mortality from census data: experience in Latin America.

Authors:  Kenneth Hill; Bernardo L Queiroz; Laura Wong; Jorge Plata; Fabiana Del Popolo; Jimmy Rosales; Cynthia Stanton
Journal:  Bull World Health Organ       Date:  2009-04       Impact factor: 9.408

2.  Maternal mortality in Malawi, 1977-2012.

Authors:  Tim Colbourn; Sonia Lewycka; Bejoy Nambiar; Iqbal Anwar; Ann Phoya; Chisale Mhango
Journal:  BMJ Open       Date:  2013-12-18       Impact factor: 2.692

3.  Protective effect of pregnancy in rural South Africa: questioning the concept of "indirect cause" of maternal death.

Authors:  Michel Garenne; Kathleen Kahn; Mark Collinson; Xavier Gómez-Olivé; Stephen Tollman
Journal:  PLoS One       Date:  2013-05-13       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.